doi:10.1016/j.virs.2024.08.005

[1]
Yuanyuan Qu, Xueyan Zhang, Meiyu Wang, Lina Sun, Yongzhong Jiang, Cheng Li, Wei Wu, Zhen Chen, Qiangling Yin, Xiaolin Jiang, Yang Liu, Chuan Li, Jiandong Li, Tianlei Ying, Dexin Li, Faxian Zhan, Youchun Wang, Wuxiang Guan, Shiwen Wang, Mifang Liang, 2021: Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants, Virologica Sinica, 36, 934-947. doi: 10.1007/s12250-021-00409-4
[2]
Weiyi Yu, Xianying Chen, Qiubing Chen, Peixuan Chen, Naizhang Liu, Yingjian Li, Xue Tan, Qiuhan Zhang, Yan Rao, Ming Guo, Zhixiang Huang, Xin Wang, Zhen Zhang, Wenjie Xiang, Yuzhen Zhang, Qianyun Liu, Hao Yin, Li Zhou, Yu Chen, Ke Lan, 2025: A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression, Virologica Sinica, 40, 793-803. doi: 10.1016/j.virs.2025.09.001
[3]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
[4]
Kangyin Li, Qi Liu, Yan Wu, Bihao Wu, Shaohong Chen, Xinghai Zhang, Xiaoying Jia, Rui Gong, Yucai Peng, Huajun Zhang, Sandra Chiu, 2024: A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1, Virologica Sinica, 39, 833-835. doi: 10.1016/j.virs.2024.08.003
[5]
Fan Shen, Chun Liang, Cui-Xian Yang, Ying Lu, An-Qi Li, Ying Duan, Mi Zhang, Ren-Rong Tian, Xing-Qi Dong, Yong-Tang Zheng, Wei Pang, 2024: SARS-CoV-2 breakthrough infections following inactivated vaccine vaccination induce few neutralizing antibodies against the currently emerging Omicron XBB variants, Virologica Sinica, 39, 173-176. doi: 10.1016/j.virs.2023.11.007
[6]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[7]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
[8]
Yanxing Cai, Wei Xu, Chenjian Gu, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, 2020: Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit, Virologica Sinica, 35, 857-860. doi: 10.1007/s12250-020-00305-3
[9]
Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu, Manli Wang, 2023: Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo, Virologica Sinica, 38, 257-267. doi: 10.1016/j.virs.2022.12.007
[10]
Jinliang Liu, Shiyu Dai, Manli Wang, Zhihong Hu, Hualin Wang, Fei Deng, 2016: Virus like particle-based vaccines against emerging infectious disease viruses, Virologica Sinica, 31, 279-287. doi: 10.1007/s12250-016-3756-y
[11]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[12]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[13]
Jia Quan, Xiangjun Zhang, Yuanfu Ding, Shengke Li, Yang Qiu, Ruibing Wang, Xi Zhou, 2021: Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses, Virologica Sinica, 36, 1165-1176. doi: 10.1007/s12250-021-00404-9
[14]
Qiu-Yan Zhang, Jia-Qi Li, Qi Li, Yang Zhang, Zhe-Rui Zhang, Xiao-Dan Li, Hong-Qing Zhang, Cheng-Lin Deng, Feng-Xia Yang, Yi Xu, Bo Zhang, 2024: Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening, Virologica Sinica, 39, 301-308. doi: 10.1016/j.virs.2024.02.006
[15]
Xiaorui Xing, Lei Wang, Zhen Cui, Wangjun Fu, Tao Zheng, Lili Qin, Pingju Ge, Aidong Qian, Nan Wang, Shuai Yuan, 2022: Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants, Virologica Sinica, 37, 938-941. doi: 10.1016/j.virs.2022.11.003
[16]
Jielin Tang, Muqing Fu, Chonghui Xu, Bao Xue, Anqi Zhou, Sijie Chen, He Zhao, Yuan Zhou, Jizheng Chen, Qi Yang, Xinwen Chen, 2023: Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection, Virologica Sinica, 38, 767-777. doi: 10.1016/j.virs.2023.06.003
[17]
Jiawei Xiao, Donghua Guo, Xiaoxu Xing, Limin Jiang, Shanshan Qi, Jun Wang, Wenfei Bai, Shiping Yu, Fanbo Shen, Xingyang Guo, Xinglin Wang, Wei Zhou, Hansong Li, Feiyu Zhao, Li Feng, Jialin Zhang, Yaru Xu, Dan Yang, Haixin Liu, Dongbo Sun, 2026: Phloretin targeting the 3CLpro Cys144 exhibits broad-spectrum antiviral activity against swine enteric coronavirus, Virologica Sinica, 41, 208-226. doi: 10.1016/j.virs.2026.02.011
[18]
Miaomiao Lin, Lele Xiong, Wen Li, Lingyan Xiao, Wei Zhang, Xiaogui Zhao, Yishan Zheng, 2025: Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii, Virologica Sinica, 40, 587-600. doi: 10.1016/j.virs.2025.06.003
[19]
Yuhan Gong, Junwen Liu, Wenxuan Ding, Yuxing Yan, Xue Hu, Gary Wong, Huaijie Jia, Zhengxiang Wang, Xin Li, Jiayi Chen, Xin Zhang, Chao Shan, Shuai Xu, Xiaoxia Wang, 2026: Antiviral activity of Saponin C from Liriope muscari against influenza A virus and SARS-CoV-2, Virologica Sinica, 41, 662-675. doi: 10.1016/j.virs.2026.06.002
[20]
Zhao-rui Zhou, Man-li Wang, Fei Deng, Tian-xian Li, Zhi-hong Hu, Hua-lin Wang, 2011: Production of CCHF Virus-Like Particle by a Baculovirus-Insect Cell Expression System, Virologica Sinica, 26, 338-346. doi: 10.1007/s12250-011-3209-6